Nontuberculous mycobacteria in non-HIV patients: Epidemiology, treatment and response

European Respiratory Journal

Volumn 23, Issue 5, 2004, Pages 741-746

  Henry, Michael T ^a   Inamdar, L ^b   O'Riordain, D ^a   Schweiger, M ^b   Watson, J P ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b Leeds Health Authority   (United Kingdom)

Author keywords

Epidemiology; Nontuberculous mycobacterium; Response to treatment guidelines

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; RIFABUTIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC TEST; EPIDEMIOLOGICAL DATA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG INFECTION; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; OUTCOMES RESEARCH; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

ADULT; ENGLAND; HUMANS; INCIDENCE; INTERNAL MEDICINE; LUNG DISEASES; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM INFECTIONS; PRACTICE GUIDELINES; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 2442510195     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00114004     Document Type: Review

References (34)

1. Marks J, Jenkins PA. The opportunist mycobacteria - 20 year reterospect. Postgrad Med J 1971; 47: 705-709.
2. Banks J, Hunter A, Campbell IA, Smith AP. Pulmonary infection with Mycobacterium kansasii in Wales 1970-1979: a review of treatment and response. Thorax 1983; 38: 271-274.
3. Hunter AM, Campbell IA, Jenkins PA, Smith AP. Treatment of pulmonary infections caused by the Mycobacterium avium intracellulare complex. Thorax 1981; 36: 326-329.
4. Huang JH, Kao PN, Adi V, Ruoss SJ. Mycobacterium avium intracellulare pulmonary infections in HIV-negative patients without pre-existing lung disease. Chest 1999; 115: 1033-1040.
5. Henriques B, Hoffner SE, Petrini B, Juhlin I, Wahlen P, Kallenius G. Infection of Mycobacterium malmoense in Sweden: Report of 221 cases. Clin Infect Dis 1994; 18: 596-600.
6. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium xenopi. Review of treatment and response. Thorax 1984; 39: 376-382.
7. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002; 23: 553-568.
8. McGarvey J, Bermudez LE. Pathogenesis of nontuberculous mycobacteria infection. Clin Chest Med 2002; 23: 569-584.
9. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium Complex in patients without predisposing conditions. N Engl J Med 1989; 321: 863-868.
10. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987; 135: 1007-1014.
11. Lambden K, Watson JM, Knerer G, Ryan MJ, Jenkins PA. Opportunist mycobacteria in England and Wales 1982-1994. CDR Review 1996; 11: 147-151.
12. American Thoracic Society. Wallace RJ Jr, Glassroth J, et al.. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S1-S25.
13. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000; 55: 210-218.
14. 2001 UK Census: Office for Population, Censuses and Surveys. www.statistics.gov.uk/census2001/profiles/ooda.asp# ethnic. Date last updated: September 2003. Date accessed: December 2003.
15. Carstairs V, Morris R. Deprivation and health in Scotland. Aberdeen, Aberdeen University Press, 1991.
16. Catanzaro A. Diagnosis, differentiating colonisation, infection and disease. Clin Chest Med 2002; 23: 599-602.
17. Wolinski E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long term follow up. Clin Infect Dis 1995; 20: 954-963.
18. Travis WD, Travis LB, Roberts GD, Su DW, Weiland LW. The histopatological spectrum in Mycobacterium marinum infection. Arch Pathol Lab Med 1985; 109: 1109-1113.
19. British Thoracic Society. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment of rifampicin and ethambutol. Thorax 1994; 49: 442-445.
20. British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M. avium intracellulare, M. malmoense and M. xenopi in HIV-negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001; 56: 167-172.
21. Banks J, Jenkins PA. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of nontuberculous mycobacteria. Thorax 1987; 42: 838-842.
22. Reich JM, Johnson RE. Mycobactereium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. Am Rev Respir Disease 1991; 143: 1381-1385.
23. British Thoraacic Society. Pulmonary disease caused by M. malmoense in HIV negative patients. 5-year follow-up of patients receiving standardised treatment. Eur Respir J 2003; 21: 478-482.
24. Askamit TR. Mycobacterium avium complex pulmonary disease in patients with pre-exisiting lung disease. Clin Chest Med 2002; 23: 643-654.
25. Griffith DE. Management of disease due to Mycobacterium kansasii. Clin Chest Med 2002; 23: 613-622.
26. Heifets LB. Susceptibly testing for Mycobacterium avium isolates. Antimicrob Agents Chemother 1996; 40: 1759-1767.
27. Heifets LB. Synergistic effect of rifampicin, streptomycin, ethionamide and ethambutamol on Mycobacterium intracellulare. Am Rev Respir Dis 1982; 125: 43-48.
28. National Committee for Clinical Laboratory Standards. Susceptibility testing for Mycobacteria, Nocardia and other anaerobic Actinomycetes. Tentative standard 2nd Edn. NCCLS document M24T2. Wayne, PA, National committee for clinical laboratory standards, 2000.
29. Iseman MD. Mycobacterium avium complex and the normal host: the other side of the coin. N Engl J Med 1989; 321: 896-898.
30. Kennedy MP, O'Connor TM, Ryan C, Sheehan S, Cryan B, Bredin C. Nontuberculous mycobacteria: incidence in Southwest Ireland from 1987 to 2000. Respir Med 2003; 97: 257-263.
31. O'Brien DP, Currie BJ, Krause VL. Nontuberculous mycobacterial disease in northern Australia: case series and review of the literature. Clin Infect Dis 2000; 31: 958-967.
32. O'Brien RJ, Geiter LJ, Snider DE. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987; 135: 1017-1024.
33. Good RC, Snider DE. Isolation of non-tuberculous mycobacteria in the United States, 1980. J Infect Dis 1980; 146: 829-833.
34. Goldman JM, Teale C, Cundall DB, Pearson SB. Childhood tuberculosis in Leeds, 1982-1990: social and ethnic factors and the role of the contact clinic in diagnosis. Thorax 1994; 49: 184-185.